Banner - Collaborative Care Symposium
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Kaleb Abbott, OD, MS, FAAO, FOWNS

Advertisement

Articles by Kaleb Abbott, OD, MS, FAAO, FOWNS

Graphic of eye drop on eye Image credit: AdobeStock/dundanim

Drs Kaleb Abbott, Andrew Pucker suggest changing "artificial tear" terminology

ByKaleb Abbott, OD, MS, FAAO, FOWNS,Andrew D. Pucker, OD, PhD, FAAO, FSLS, FBCLA,Jordana Joy, Associate Editor
December 10th 2025

The eye care providers authored an opinion article that has been published in "The Ocular Surface."

Advertisement

Latest Updated Articles

  • Graphic of eye drop on eye Image credit: AdobeStock/dundanim
    Drs Kaleb Abbott, Andrew Pucker suggest changing "artificial tear" terminology

    Published: December 10th 2025 | Updated:



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

Pilocarpine 0.4%: Significant decrease in pupillary diameter in presbyopic patients

2

ODs predict 2026: What's to come in technology, dry eye, and glaucoma

3

SpyGlass Pharma randomizes first patients in 2 phase 3 clinical trials of the BIM-IOL System

4

The current state of contact lens technology

5

The unmet needs of glaucoma care with Dr Ben Casella

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us